首页> 外文期刊>Molecular medicine reports >Protective function of pyridoxamine on retinal photoreceptor cells via activation of the p-Erk1/2/Nrf2/Trx/ASK1 signalling pathway in diabetic mice
【24h】

Protective function of pyridoxamine on retinal photoreceptor cells via activation of the p-Erk1/2/Nrf2/Trx/ASK1 signalling pathway in diabetic mice

机译:吡ido胺通过激活p-Erk1 / 2 / Nrf2 / Trx / ASK1信号通路对糖尿病小鼠的视网膜感光细胞的保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

The present study aimed to investigate the mechanisms that mediate the protective effects of pyridoxamine (PM) on light-damaged retinal photoreceptor cells in diabetic mice. A high-fat diet and streptozotocin were used to induce a mouse model of type II diabetes. During the experiment, mice were divided the mice into three types of group, as follows: Control groups (negative control and light-damaged groups); experimental groups (diabetic and diabetic light-damaged groups); and treatment groups (25, 50 and 100 mg/kg PM-treated groups). Using hematoxylin-eosin staining, the number of nuclear layer cells were counted. Western blotting and immunohistochemistry were performed to measure the levels of thioredoxin (Trx), phospho-extracellular signal-regulated kinase 1/2 (p-Erk1/2), nuclear factor erythroid 2-related factor 2 (Nrf2) and apoptosis signal-regulating kinase 1 (ASK1). The photoreceptor cell count in the outer nuclear layer of the light-damaged, diabetic control and diabetic light-damaged groups were significantly reduced compared with the negative control group (P<0.001). The cell counts in the PM-treated groups were significantly increased compared with the diabetic group (P<0.001). Compared with the negative control group, the light-damaged, diabetic and diabetic light-damaged groups exhibited significantly decreased Trx, p-Erk1/2 and Nrf2 expression levels (P<0.001), and significantly increased ASK1 expression levels (P<0.001). However, in the PM-treated groups, Trx, p-Erk1/2 and Nrf2 expression levels were significantly increased (P<0.001), and ASK1 expression was significantly decreased (P<0.001). The results of the present study demonstrate that PM protects retinal photoreceptor cells against light damage in diabetic mice, and that its mechanism may be associated with the upregulation of Trx, p-Erk1/2 and Nrf2 expression, and the downregulation of ASK1 expression.
机译:本研究旨在研究介导吡ido胺(PM)对糖尿病小鼠光损伤的视网膜感光细胞的保护作用的机制。高脂饮食和链脲佐菌素用于诱导II型糖尿病小鼠模型。在实验过程中,将小鼠分为三种类型的组,如下:对照组(阴性对照组和光损伤组);和对照组。实验组(糖尿病和糖尿病轻伤组);和治疗组(25、50和100 mg / kg PM治疗组)。使用苏木精-伊红染色,计数核层细胞数。进行了蛋白质印迹和免疫组化实验,以测定硫氧还蛋白(Trx),磷酸化细胞外信号调节激酶1/2(p-Erk1 / 2),核因子红系2相关因子2(Nrf2)和细胞凋亡信号的水平。激酶1(ASK1)。与阴性对照组相比,光损伤,糖尿病对照组和糖尿病光损伤组的外核层中的感光细胞计数显着降低(P <0.001)。与糖尿病组相比,PM治疗组的细胞计数显着增加(P <0.001)。与阴性对照组相比,光损伤,糖尿病和糖尿病光损伤组的Trx,p-Erk1 / 2和Nrf2表达水平显着降低(P <0.001),而ASK1表达水平显着升高(P <0.001)。 。然而,在PM治疗组中,Trx,p-Erk1 / 2和Nrf2表达水平显着升高(P <0.001),而ASK1表达显着降低(P <0.001)。本研究结果表明,PM保护糖尿病小鼠视网膜感光细胞免受光损伤,其机制可能与Trx,p-Erk1 / 2和Nrf2表达的上调以及ASK1表达的下调有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号